Breast cancer prevention study aims to overcome drug bias
- PMID: 11242406
Breast cancer prevention study aims to overcome drug bias
Comment in
-
Raloxifene for breast cancer prevention.JAMA. 2001 Apr 25;285(16):2079. doi: 10.1001/jama.285.16.2079. JAMA. 2001. PMID: 11311092 No abstract available.
Similar articles
-
STAR trial reports.Eur J Cancer. 2006 Aug;42(12):1694. Eur J Cancer. 2006. PMID: 16998956 No abstract available.
-
Tamoxifen versus raloxifene in the prevention of breast cancer.Eur J Cancer. 2002 Nov;38 Suppl 6:S20-1. doi: 10.1016/s0959-8049(02)00271-x. Eur J Cancer. 2002. PMID: 12409060 No abstract available.
-
Breast cancer hopes.Nurs Spectr (Wash D C). 1998 Jun 1;8(11):17-8. Nurs Spectr (Wash D C). 1998. PMID: 10542741 No abstract available.
-
Breast cancer prevention.Clin Obstet Gynecol. 2001 Sep;44(3):478-84. doi: 10.1097/00003081-200109000-00004. Clin Obstet Gynecol. 2001. PMID: 11685873 Review. No abstract available.
-
Tamoxifen prevention of breast cancer: an instance of the fingerpost.J Natl Cancer Inst. 1999 Nov 3;91(21):1809-19. doi: 10.1093/jnci/91.21.1809. J Natl Cancer Inst. 1999. PMID: 10547388 Review. No abstract available.
Cited by
-
Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.Drug Saf. 2001;24(14):1039-53. doi: 10.2165/00002018-200124140-00003. Drug Saf. 2001. PMID: 11735660 Review.
-
Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.J Gen Intern Med. 2002 Sep;17(9):689-95. doi: 10.1046/j.1525-1497.2002.11024.x. J Gen Intern Med. 2002. PMID: 12220365 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical